Volume 12, Number 5—May 2006
THEME ISSUE
Tuberculosis Special Section
Perspective
Universal Genotyping in Tuberculosis Control Program, New York City, 2001–2003
Carla M. Clark*
, Cynthia R. Driver*, Sonal S. Munsiff*†, Jeffrey R. Driscoll‡, Barry N. Kreiswirth§, Benyang Zhao¶, Adeleh Ebrahimzadeh¶, Max Salfinger‡, Amy S. Piatek*, Jalaa' Abdelwahab†, and the New York City Molecular Epidemiology Working Group
, Cynthia R. Driver*, Sonal S. Munsiff*†, Jeffrey R. Driscoll‡, Barry N. Kreiswirth§, Benyang Zhao¶, Adeleh Ebrahimzadeh¶, Max Salfinger‡, Amy S. Piatek*, Jalaa' Abdelwahab†, and the New York City Molecular Epidemiology Working Group
Figure
Figure. Median days for submission and turnaround time by laboratory, New York City, 2001–2003. PHL, public health laboratory; RFLP, restriction fragment length polymorphism.
1In addition to the authors, members of the New York City Genotyping Working Group include Tracy Agerton, Sara Beatrice, Roseann Costarella, Rafael Fernandez, Dolores Gallagher, Karen Granville, Natalia Kurepina, Fabienne Laraque, Jiehui Li, Michelle Macaraig, Barun Mathema, Lucille Palumbo, Linda Parsons, Alex Ravikovitch, Harry Taber, Rachel Wiseman, and Genet Zickas.
Page created: January 06, 2012
Page updated: January 06, 2012
Page reviewed: January 06, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential
